The largest database of trusted experimental protocols

Mir 214 mimic

Manufactured by GenePharma
Sourced in China

MiR-214 mimic is a synthetic RNA molecule designed to mimic the function of the naturally occurring microRNA miR-214. microRNAs are small, non-coding RNA molecules that play a role in regulating gene expression. The MiR-214 mimic is a laboratory tool used to study the biological functions and effects of miR-214 in experimental settings.

Automatically generated - may contain errors

13 protocols using mir 214 mimic

1

Klf4 Overexpression Plasmid and miRNA Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Klf4 overexpression Klf4 plasmid was obtained from the scientific research group of Professor Keping Xie (University of Texas, MD Anderson Cancer Center, Houston, TX, USA). siKlf4 (forward primer, 5′-AUCGUUGAACUCCUCGGUCUCUCUC-3′; reverse primer, 5′-GAGAGAGACCGAGGAGUUCAACGAU-3′) was synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China), as were miR-9-5p mimic (forward, 5′-UCUUUGGUUAUCUAGCUGUAUGA-3′; reverse, 5′-UUAGAAACCAAUAGAUCGACAUA-3′), miR-9-5p inhibitor (5′-UCAUACAGCUAGAUAACCAAAGA-3′), miR-9-5p inhibitor negative control (NC; 5′-CAGUACUUUUGUGUAGUACAA-3′), mimic NC (forward, 5′-UUCUCCGAACGUGUCACGUTT-3′; reverse, 5′-ACGUGACACGUUCGGAGAATT-3′), miR-128 mimic (forward, 5′-UCACAGUGAACCGGUCUCUUU-3′; reverse, 5′-AGAGACCGGUUCACGGUGAUU-3′), miR-449a mimic (forward, 5′-UGGCAGUGUAUUGUUAGCUGGU-3′; reverse, 5′-CAGCUAACAAUACACUGCAAUU-3′) and miR-214 mimic (forward, 5′-ACAGCAGGCACAGACAGGCAG-3′; reverse, 5′-GCCUGUCUGUGCCUGCUGUUU-3′).
+ Open protocol
+ Expand
2

miR-214 Modulation in PDLSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-214 mimic (sense, 5′-aca gca gg cac aga cag gca gu-3′ and antisense, 5′-ugc cug ucu gug ccu gcu guu u-3′), mimic negative control (NC; sense, 5′-uuc ucc gaa cgu guc acg utt-3′ and antisense, 5′-acg uga cac guu cgg aga att-3′), miR-214 inhibitor (5′-ugc cug ucu gug ccu gcu guu u-3′) and inhibitor negative control (5′-cag uac uuu ugu gua gua caa-3′) were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China). PDLSCs (1×106 cells/well) were plated in a six-well plate 1 day prior to transfection. PDLSCs were then transfected with miR-214 mimic, mimic NC, miR-214 inhibitor or inhibitor NC, at a final concentration of 25 nM, using siLentFect Lipid Reagent (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Subsequently, cells were cultured in serum-free Dulbecco's modified Eagle's medium: Nutrient Mixture F-12 (Shanghai GeneChem Co., Ltd., Shanghai, China). Following 4 h of incubation at 37°C, the medium was replaced with DMEM/F12 supplemented with 10% FBS. The cells were harvested for further experiments at 48 h after transfection.
+ Open protocol
+ Expand
3

Ectopic Expression of miR-214 and LINC0086 in NPC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The two EBV+ NPC cell lines (C666-1 and HK-1) were obtained from the Cellbank of the Chinese Academy of Sciences. Cells were grown routinely in RPMI-1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Gibco, Carlsbad, CA, USA) and cultured in a 37°C humidified atmosphere with 5% CO2. Ectopic expression of miR-214 in cells was achieved by transfection with miR-214 mimic (GenePharma, Shanghai, P.R. China) using Lipofectamine 3000 (Invitrogen). Overexpression of LINC0086 was achieved by using lentivirus containing LINC0086-expressed plasmid (GeneCopoecia, Guangzhou, P.R. China). Cells were plated into 6-well clusters or 96-well plates and transfected for 24 or 48 h. Transfected cells were used in further assays.
+ Open protocol
+ Expand
4

Modulating TUG1, miR-214, and BMP2 in Cell Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNA (siRNA) targeting TUG1 (si-TUG1; 20 nM), siRNA-negative control (si-NC; 20 nM), microRNA (miR)-214 mimic (30 nM), miR-NC (final concentration, 30 nM), miR-214 inhibitor (15 nM), NC inhibitor (15 nM), bone morphogenetic protein 2 (BMP2) mimics (30 nM) and NC mimic (30 nM) were synthesized by Shanghai GenePharma Co., Ltd. Transfection was performed using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) at 37˚C for 48 h, after which the cells were harvested for reverse transcription-quantitative (RT-q)PCR analysis or western blotting. The sequences were shown as follows: si-TUG1 5'-GCUUGGCUUCUAUUCUGAAUCCUUU-3'; scrambled si-NC 5'-TTCTCCGAACGTGTCACGTTT-3'; miR-214 mimic 5'-ACAGCAGGCACAGACAGGCAGU-3'; scrambled miR-NC 5'-TTCTCCGAACGTGTCACGTTT-3'; miR-214 inhibitor 5'-ACGTGACACGTTCGGAGAATT-3'; scrambled NC inhibitor 5'-CAGTACTTTTGTGTAGTACAA-3'; BMP2 mimic 5'-ACCCGCTGTCTTCTAGCGT-3'; and scrambled NC mimic 5'-ACGUGACACGUUCGGAGAATT-3'.
+ Open protocol
+ Expand
5

Molecular Profiling of miR-214 and AMPK

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-214 mimic, miR-214 inhibitor, negative control (NC) mimic, and NC inhibitor were purchased from GenePharma (Shanghai, China). Their sequences were previously described (15 (link)). Two siRNAs for AMPK (accession number: MF989224) were synthesized from GenePharma (Shanghai, China). The sequences of the first one were: 5′-CCUCCAGUAUCAAGAUCUUTT-3′ (forward) and 5′-AAGAUCUUGAUACUGGAGGTT-3′ (reverse); the sequences of the second one were: 5′-GGACACGCCCAUUAUUAAATT-3′ (forward) and 5′-UUUAAUAAUGGGCGUGUCCTT-3′ (reverse).
The antibodies against G protein of SHVV and AMPK were produced and stored in our laboratory. The antibody against β-actin was purchased from Bioss Biotechnology Co., LTD. (Beijing, China). The secondary antibody donkey anti-rabbit IgG antibody was purchased from Gene Co., LTD. (Shanghai, China).
+ Open protocol
+ Expand
6

Immortalized Keratinocyte and CSCC Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human immortal keratinocyte line HaCaT and CSCC cells, including A431, SCC13,
HSC-5, SCL-I cells as well as 293T cells were from American Type Culture
Collection (Manassas, VA, USA) and grown in Dulbecco’s modified Eagle’s medium
(DMEM; Thermo Fisher) supplemented with 10% fetal bovine serum (FBS, Gibco,
Carlsbad, CA, USA) and 1% penicillin/streptomycin (Sigma-Aldrich Chemical
Company, St Louis, MO, USA). The cells were kept in a culture environment with
5% CO2 at 37°C. miR-214 mimic, VEGFA overexpression (OE) and Bcl-2 OE
were synthesized by GenePharma Co., Ltd. (Shanghai, China). All fragments were
loaded into pCMV-MC plasmids (Biovector Science Lab, Beijing, China) for the
following transfection procedure which was carried out using a Cell Line
Nucleofector Kit V (Amaxa Biosystems, Koln, Germany). The transfection efficacy
was assessed by RT-qPCR.
+ Open protocol
+ Expand
7

Hypoxia-Reoxygenation Stress Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
si-NC, si-CircZNF609, si-PTGS2, NC mimic, NC inhibitor, miR-214 mimic, and miR-214-3p inhibitor were synthesized by GenePharma (Shanghai, China). Lipofectamine 3000 (Invitrogen) were used to perform the transfection according to the manufacturer’s instruction. After 48 h, cells were treated by H/R stimulation or harvested for followed assays.
+ Open protocol
+ Expand
8

Transfection of Primary PASMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-214 inhibitor, the miR-214 mimic and negative controls were obtained from Shanghai GenePharma (Shanghai, China). Transfection of primary PASMCs was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. For transfection, chemosynthesized siRNA (anti-CCNL2 siRNA: 5′-CTCGGAAAAAGGTTGATCTC-3′), an miR-214 mimic (5′-ACAGCAGGCACAGACAGGCAGU-3′), an miR-214 inhibitor (5′-ACUGCCUGUCUGUGCCUGCUGU-3′), or a scramble control (5′-CAGUACUUUUGUGUAGUACAA-3′) was dissolved in RNase-free water to a concentration of 20 mM to prepare a stock solution. PASMCs were plated at a density of 1.2 × 105 cells/well in 6-well culture plates, and transfection with siRNA, miRNA mimics/inhibitors or the scramble control at a final concentration of 50 nM or 100 nM was performed after 24 h in culture. The cells were allowed to grow for an additional 48 h after transfection and were then treated as indicated below.
+ Open protocol
+ Expand
9

Establishing NSCLC Cell Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human normal lung bronchial epithelium cell line BEAS-2B and NSCLC cell line H460, H1299 and A549 were obtained from American Type Culture Collection (Manassas, VA) and were routinely tested for absence of mycoplasma using a Mycoplasma Detection Kit (Bitool, China) in our laboratory. All cell lines were maintained in DMEM supplemented with 10% fetal bovine serum. bFGF, EGF and B27 were purchased from Invitrogen (Carlsbad, CA). SFN was from LKT Laboratories. Cisplatin, Hoechst33342 and propidium iodide were from Sigma-Aldrich (St Louis, MO). Antibodies against c-MYC, Cyclin E, EZH2, Survivin, and p53 were acquired from Abcam (Cambridge, UK). Caspase 3 and cleaved Caspase 3 were from Cell Signaling, Inc (Danvers, MA). β-catenin and PTEN were from Santa Cruz Biotechnology, Inc (Santa Cruz, CA). miRNAs and vectors were transfected using Lipofectamine 2000 reagent (Invitrogen). The miR-214 mimic, negative control, and miR-214 inhibitor were purchased from GenePharma (Suzhou, China).
+ Open protocol
+ Expand
10

miR‐214 Overexpression in Transfected Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with negative control and miR‐214 mimic (30 nM, Genepharma) with siRNA‐mate (Genepharma, Suzhou, China) for 6 hours, and used 48 hours posttransfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!